Phase III clinical trial for biosimilar etanercept

Sandoz, the global leader in biosimilars, announced it has initiated a major Phase III clinical trial with its biosimilar version of etanercept (Amgen's Enbrel®).
Source: Pharmacy Europe - Category: Drugs & Pharmacology Source Type: news